Ken Takasawa

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

Biomolecules

Molecular cancer

Biomedicines

Journal of personalized medicine

RIKEN Advanced Institute for Computational Science

This page only lists publications with an associated author ORCID identifier.

Affiliation History

RIKEN Advanced Institute for Computational Science Apr 01 2019

Japan

Researcher (Post-Doc) :: Cancer Translational Research Team

University of Miyazaki Apr 01 2018 - Mar 31 2019

Japan

Researcher (Post-Doc) :: Agriculture

Japan Society for the Promotion of Science Apr 01 2015 - Mar 31 2018

Japan

DC1 :: Miyazaki Univ. (Laboratory of Veterinary Biochemistry and Molecular Biology)

Publications

Syuzo Kaneko, Ken Takasawa, Ken Asada, Kouya Shiraishi, Noriko Ikawa, Hidenori Machino, Norio Shinkai, Maiko Matsuda, Mari Masuda, Shungo Adachi, Satoshi Takahashi, Kazuma Kobayashi, Nobuji Kouno, Amina Bolatkan, Masaaki Komatsu, Masayoshi Yamada, Mototaka Miyake, Hirokazu Watanabe, Akiko Tateishi, Takaaki Mizuno, Yu Okubo, Masami Mukai, Tatsuya Yoshida, Yukihiro Yoshida, Hidehito Horinouchi, Shun-Ichi Watanabe, Yuichiro Ohe, Yasushi Yatabe, Vassiliki Saloura, Takashi Kohno, Ryuji Hamamoto
Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations. Molecular cancer 23 (1) (2024)
Syuzo Kaneko, Ken Takasawa, Ken Asada, Kouya Shiraishi, Noriko Ikawa, Hidenori Machino, Norio Shinkai, Maiko Matsuda, Mari Masuda, Shungo Adachi, Satoshi Takahashi, Kazuma Kobayashi, Nobuji Kouno, Amina Bolatkan, Masaaki Komatsu, Masayoshi Yamada, Mototaka Miyake, Hirokazu Watanabe, Akiko Tateishi, Takaaki Mizuno, Yu Okubo, Masami Mukai, Tatsuya Yoshida, Yukihiro Yoshida, Hidehito Horinouchi, Shun-Ichi Watanabe, Yuichiro Ohe, Yasushi Yatabe, Vassiliki Saloura, Takashi Kohno, Ryuji Hamamoto
Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations. Molecular cancer 23 (1) (2024)
Syuzo Kaneko, Ken Takasawa, Ken Asada, Kouya Shiraishi, Noriko Ikawa, Hidenori Machino, Norio Shinkai, Maiko Matsuda, Mari Masuda, Shungo Adachi, Satoshi Takahashi, Kazuma Kobayashi, Nobuji Kouno, Amina Bolatkan, Masaaki Komatsu, Masayoshi Yamada, Mototaka Miyake, Hirokazu Watanabe, Akiko Tateishi, Takaaki Mizuno, Yu Okubo, Masami Mukai, Tatsuya Yoshida, Yukihiro Yoshida, Hidehito Horinouchi, Shun-Ichi Watanabe, Yuichiro Ohe, Yasushi Yatabe, Vassiliki Saloura, Takashi Kohno, Ryuji Hamamoto
Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations. Molecular cancer 23 (1) (2024)
Ken Asada, Ken Takasawa, Hidenori Machino, Satoshi Takahashi, Norio Shinkai, Amina Bolatkan, Kazuma Kobayashi, Masaaki Komatsu, Syuzo Kaneko, Koji Okamoto, Ryuji Hamamoto
Single-Cell Analysis Using Machine Learning Techniques and Its Application to Medical Research. Biomedicines 9 (11) (2021)
Syuzo Kaneko, Ken Takasawa, Ken Asada, Norio Shinkai, Amina Bolatkan, Masayoshi Yamada, Satoshi Takahashi, Hidenori Machino, Kazuma Kobayashi, Masaaki Komatsu, Ryuji Hamamoto
Epigenetic Mechanisms Underlying COVID-19 Pathogenesis. Biomedicines 9 (9) (2021)
Ken Asada, Masaaki Komatsu, Ryo Shimoyama, Ken Takasawa, Norio Shinkai, Akira Sakai, Amina Bolatkan, Masayoshi Yamada, Satoshi Takahashi, Hidenori Machino, Kazuma Kobayashi, Syuzo Kaneko, Ryuji Hamamoto
Application of Artificial Intelligence in COVID-19 Diagnosis and Therapeutics. Journal of personalized medicine 11 (9) (2021)
Ken Asada, Amina Bolatkan, Ken Takasawa, Masaaki Komatsu, Syuzo Kaneko, Ryuji Hamamoto
Critical Roles of N6-Methyladenosine (m6A) in Cancer and Virus Infection. Biomolecules 10 (7) (2020)
Ryuji Hamamoto, Kruthi Suvarna, Masayoshi Yamada, Kazuma Kobayashi, Norio Shinkai, Mototaka Miyake, Masamichi Takahashi, Shunichi Jinnai, Ryo Shimoyama, Akira Sakai, Ken Takasawa, Amina Bolatkan, Kanto Shozu, Ai Dozen, Hidenori Machino, Satoshi Takahashi, Ken Asada, Masaaki Komatsu, Jun Sese, Syuzo Kaneko
Application of Artificial Intelligence Technology in Oncology: Towards the Establishment of Precision Medicine. Cancers 12 (12) (2020)
Ken Asada, Kazuma Kobayashi, Samuel Joutard, Masashi Tubaki, Satoshi Takahashi, Ken Takasawa, Masaaki Komatsu, Syuzo Kaneko, Jun Sese, Ryuji Hamamoto
Uncovering Prognosis-Related Genes and Pathways by Multi-Omics Analysis in Lung Cancer. Biomolecules 10 (4) (2020)
Satoshi Takahashi, Ken Asada, Ken Takasawa, Ryo Shimoyama, Akira Sakai, Amina Bolatkan, Norio Shinkai, Kazuma Kobayashi, Masaaki Komatsu, Syuzo Kaneko, Jun Sese, Ryuji Hamamoto
Predicting Deep Learning Based Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Reverse Phase Protein Array Data. Biomolecules 10 (10) (2020)
Ryuji Hamamoto, Masaaki Komatsu, Ken Takasawa, Ken Asada, Syuzo Kaneko
Epigenetics Analysis and Integrated Analysis of Multiomics Data, Including Epigenetic Data, Using Artificial Intelligence in the Era of Precision Medicine. Biomolecules 10 (1) (2019)

Ken Takasawa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ken Takasawa